Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to -$133272.0.

  • Pharma-Bio Serv's Profit After Tax rose 1353.27% to -$133272.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$637662.0, marking a year-over-year increase of 5047.62%. This contributed to the annual value of -$637662.0 for FY2025, which is 5047.62% up from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Profit After Tax is -$133272.0, which was up 1353.27% from -$313877.0 recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Profit After Tax registered a high of $2.3 million during Q3 2021, and its lowest value of -$4.9 million during Q4 2021.
  • For the 5-year period, Pharma-Bio Serv's Profit After Tax averaged around -$76468.2, with its median value being $96439.5 (2022).
  • Examining YoY changes over the last 5 years, Pharma-Bio Serv's Profit After Tax showed a top increase of 22872.01% in 2021 and a maximum decrease of 347565.8% in 2021.
  • Over the past 5 years, Pharma-Bio Serv's Profit After Tax (Quarter) stood at -$4.9 million in 2021, then soared by 107.01% to $341640.0 in 2022, then crashed by 113.8% to -$47148.0 in 2023, then crashed by 226.91% to -$154130.0 in 2024, then increased by 13.53% to -$133272.0 in 2025.
  • Its Profit After Tax was -$133272.0 in Q4 2025, compared to -$313877.0 in Q3 2025 and -$98322.0 in Q2 2025.